We are a multinational company in the Pharmaceutical sector based in Parma (Italy), with 80 years’ experience. Our main focus is the research, development, production and marketing of innovative medicines in the following therapeutic areas: Respiratory, Neonatology, Rare Diseases and Special Care.
With a sales volume of over €1.4 billion, we are among the 50 largest pharmaceutical companies in the world. Our production plants are located in Parma (Italy), Blois (France) and Santana de Parnaíba (Brazil).
We have four research and development centers in Parma (Italy), Paris (France), Cary (USA) and Chippenham (UK), as well as the newly acquired Danish company Zymenex, which work together to bring about advances in preclinical, clinical, and regulatory programs.
The Chiesi Group currently employs approximately 4,500 people, of whom 560 are dedicated to research and development activities and 720 work in manufacturing plants in Italy, France and Brazil.
